{"basic_info": {"ticker": "2437", "exchange": "XSHE", "bloomberg_ticker": "002437 CH Equity", "name": "HARBIN GLORIA PHARMACEUTIC-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "誉衡药业", "period": "2020", "market_value": 6990030848, "total_income": 1405036205, "ccy": "人民币元", "shariah_compliance_summary": "non-compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 1127308696, "business_income_over_total_income": 0.8023342686745926}, {"shariah_compliance": "unknown", "income": 277727506, "business_income_over_total_income": 0.1976657291902311}], "details": [{"business_activity_cn": "心脑血管药物", "business_activity_en": "Cardiovascular drugs", "income": 435625873, "business_income_over_total_income": 0.31004601265773074, "shariah_compliance": "compliant"}, {"business_activity_cn": "营养类药物", "business_activity_en": "Nutrition drugs", "income": 275660160, "business_income_over_total_income": 0.1961943464652571, "shariah_compliance": "compliant"}, {"business_activity_cn": "骨科药物", "business_activity_en": "Orthopedic drugs", "income": 161216965, "business_income_over_total_income": 0.114742214062733, "shariah_compliance": "compliant"}, {"business_activity_cn": "抗感染药物", "business_activity_en": "Anti-infectives", "income": 93998739, "business_income_over_total_income": 0.06690129312361741, "shariah_compliance": "compliant"}, {"business_activity_cn": "抗肿瘤药及免疫调节剂", "business_activity_en": "Antineoplastic and immunomodulatory agents", "income": 104406151, "business_income_over_total_income": 0.07430851292547298, "shariah_compliance": "compliant"}, {"business_activity_cn": "电解质类药物", "business_activity_en": "Electrolyte drugs", "income": 56400808, "business_income_over_total_income": 0.04014188943978138, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 277727506, "business_income_over_total_income": 0.1976657291902311, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.28990912042256395, "shariah_compliance": "non-compliant", "amount_over_market_value": 0.28990912042256395}]}